J. Suboticki

机构：AbbVie (United States)

发表论文 31 篇 · 总被引 230 次 · h-index 6

代表论文

• Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials (2022 · Annals of the Rheumatic Diseases · 被引 88)
• MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis (2023 · RMD Open · 被引 31)
• Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate (2018 · Annals of the Rheumatic Diseases · 被引 31)
• Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY (2020 · Lara D. Veeken · 被引 23)
• Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial (2022 · Arthritis Research & Therapy · 被引 18)
• THU0195 INCIDENCE AND RISK OF VENOUS THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE UPADACITINIB SELECT CLINICAL TRIAL PROGRAM (2020 · Annals of the Rheumatic Diseases · 被引 10)